Variant detail

KCNH2C445R

c.1333T>C · residue 445 · C → R
HGVS annotation

ClinVar-style identity and transcript context

ClinVar-style HGVS
NM_000238.4(KCNH2):c.1333T>C (p.Cys445Arg)
HGVSc
c.1333T>C
cDNA change
c.1333T>C
RefSeq transcript
NM_000238.4
Ensembl transcript
ENST00000262186.10
Protein HGVS
p.Cys445Arg
Genomic coordinate
NC_000007.14:g.150649737A>G
LQT2 penetrance Low risk
18% 90% credible interval 3-40%
0%20%50%100%

Limited evidence · n=0 0 observed LQT2 carriers · 1.77 hypothetical affected and 8.23 hypothetical unaffected

One-sentence summary

Roughly 1 in 7 people who carry C445R are estimated to eventually be diagnosed with Long QT type 2 — low risk penetrance, based on 0 carriers reported so far.

Structure: Mild_Hotspot. Functional evidence: MAVE 0% WT.

Executive summary

Sources used for interpretation

The LQT2 penetrance estimate combines observed carrier counts with a feature-based model starting point. Other rows summarize supporting annotations for interpretation; not every row is a direct input to the model.

Estimatemodel output Observedmeasured in people/assays Model inputassumed, not observed Predictedcomputational Externalthird-party

Evidence

Carriers observed
0
0 LQT2 · 0 unaffected · 0 gnomAD
Model prior: 1.77 hypothetical affected · 8.23 hypothetical unaffected
Limited evidence
Functional data
Severe trafficking loss
MAVE 0% WT · 0 published functional studies
Predictors and density
REVELLikely damaging0.747range 0-1
LQT2 densitySparse region0.364range 0-1
PolyPhen-2Possibly damaging0.613range 0-1
PROVEANDeleterious-9.46cutoff <= -2.5
BLAST-PSSM-4lower = less tolerated
Overall4/5
Range labels show the expected scale or cutoff. Calls are rough orientation from published cutoffs (hover a row) — not a clinical classification.

Automated ACMG/AMP review prompts

Generated from available data — not a clinical classification
PS3met · strong/moderate
Functional studies or MAVE support effect
PM1review
Hotspot or high LQT2 density
PM2met · moderate
Absent or extremely rare in population data
PP3met · supporting
Computational predictors support effect
BS1not met
Allele frequency too high for disorder

Reported carrier data

Paper / cohort Carriers LQT2 / affected Unaffected / ambiguous Other observations Variant context
gnomAD population observations (v4) 0 0 LQT2 0 Population observations; not known affected cases. gnomAD v4 allele count.
Combined literature, cohort, and gnomAD 0 0 LQT2 0 Combined totals used in the penetrance estimate. Curated carrier totals for this variant.
Hypothetical observations from model prior (not observed patients) 10 1.77 hypothetical LQT2 affected 8.23 hypothetical unaffected Feature-based pseudo-counts added before observed carriers. Model input; not literature or gnomAD evidence.

Model starting point. The penetrance model starts with 1.77 hypothetical affected and 8.23 hypothetical unaffected observations derived from variant features, then updates that starting point with the real carrier counts above. As observed carrier counts grow, this feature-based starting point has less influence.

Nearby variants · researcher detail
Neighbour residueDistance (A)Observed variants
4450.0
4443.8 E444K, E444D, E444D,
4463.8
4435.4 T443fsX, T443N,
4475.4 Y447X,
4426.6
4486.6 A448T, A448S,
4417.6 P441R, P441L,
4497.6
4408.5 P440L,
4508.5
4399.3
4519.3 P451L,
43810.1 E438K, E438X,
45210.1
43710.7
45310.7
43611.4 T436M,
45411.4
43512.0 E435G, E435X,
45512.0
43412.6
45612.6 D456Y,
43313.2
45713.2 L457P,
43213.7
45813.7
43114.2 F431L, F431L, F431L,
45914.2
43014.7
46014.7 D460fsX
External resources